Concenter Biopharma Ltd. is developing a Promising Drug for Treating and Preventing Type 2 Diabetes
Concenter Biopharma is working on a novel drug to eliminate type 2 diabetes with no side effects. The drug dramatically lowers insulin resistance, the major cause of T2D, while lowering the body’s chronic and systemic inflammation levels.
Comentarios